Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$6.26 - $9.34 $13,828 - $20,632
-2,209 Reduced 38.91%
3,468 $26,000
Q3 2022

Nov 14, 2022

BUY
$6.5 - $12.67 $36,900 - $71,927
5,677 New
5,677 $40,000
Q2 2021

Feb 11, 2022

SELL
$32.22 - $44.59 $483 - $668
-15 Closed
0 $0
Q1 2021

Feb 08, 2022

BUY
$37.26 - $67.74 $558 - $1,016
15 New
15 $1,000

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $849M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track State Of Wyoming Portfolio

Follow State Of Wyoming and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.